Background. Isolated reactive serum treponemal chemiluminescence immunoassay (CIA) specimens cause clinical uncertainty.
The incidence of infectious syphilis has increased in developed countries in the last decade [1] . The epidemiology of syphilis in Australia is similar to that in other industrialized countries, with the highest incidence of infection among men who have sex with men, among people living with human immunodeficiency virus (HIV), and in indigenous communities. The incidence of infectious syphilis in Australia is 4.9 cases per 100 000 population [2] . Cheaper, quicker, and less labor-intensive diagnostic assays represent an attractive option for diagnostic laboratory services in the context of an increased volume of sera referred for laboratory screening. Treponemal enzyme immunoassays (EIAs) are quicker and easier to perform than traditional syphilis serological assays and have been widely available since the 1980s [3, 4] . More recently, validated and automated treponemal chemiluminescence immunoassays (CIAs) have been developed. In our laboratory, a CIA (Architect Syphilis TP, Abbott, Wiesbaden, Germany) has been used as the initial screening assay for syphilis since 2005 [5] . This assay uses recombinant Treponema pallidum antigens (TpN15, TpN17, and TpN47) to detect antibodies against T. pallidum in individuals with syphilis [5, 6] .
The introduction of EIAs and CIAs has been associated with a proportion of reactive EIA/CIA results that have not been confirmed to be reactive by traditional treponemal and nontreponemal assays [7] [8] [9] [10] [11] . The interpretation of apparently conflicting test results has caused confusion for laboratory and clinical staff. The potential consequences of misclassifying an isolated reactive immunoassay as negative include a missed diagnosis of early syphilis, infectious syphilis transmission, and the possibility of untreated latent disease [12] [13] [14] . There is also the possibility of missing the opportunity to test for other conditions with a common transmission route (eg, HIV infection) and to ensure appropriate contact tracing. Conversely, misclassifying an isolated reactive screening test as positive could result in unnecessary antibiotic therapy and in stress to the patient, family, and partners as a consequence of syphilis contact tracing.
One explanation for an isolated reactive CIA for syphilis in sera that are nonreactive on traditional assays is that the result represents a biological false-positive (BFP) reaction. Higher rates of BFP treponemal tests have been reported in Lyme disease and HIV infection and have been described in up to 1% of the general population [15] [16] [17] . Since the widespread use of EIA and CIA techniques for syphilis testing, some authors have concluded that an isolated reactive EIA or CIA can be dismissed as a negative result ( particularly in patients with no established risk factor) [8, 9] . Current US Centers for Disease Control Sexually Transmitted Diseases (CDC STD) treatment guidelines state that, in patients with a reactive EIA or CIA specimen but nonreactive "traditional" treponemal and nontreponemal specimens, further evaluation or treatment is not indicated [18] . We assessed the performance of the Architect Syphilis TP assay in a tertiary serology laboratory and reviewed the clinical features of a subset of patients with reactive results to assess the significance of an isolated reactive syphilis CIA specimen.
METHODS
From 1 January 2009 through 31 December 2010, clinically referred sera were screened by the CIA to detect antibodies to T. pallidum (Archictect Syphilis TP). Sera were classified as reactive if the chemiluminescent signal-to-cutoff ratio (S/CO) was ≥1.1. In accordance with the manufacturer's recommendation, such sera were centrifuged at 10 000 × g and retested in duplicate. The values reported in this study were the mean S/CO of these duplicates. The reproducibility of the CIA finding was monitored by the inclusion of a reference serum sample (PeliSpy; AcroMetrix Europe BV) each day. In sera that were reactive on CIA, reflex testing was undertaken with a T. pallidum particle agglutination (TPPA) test (Serodia TPPA, Fujirebo, Tokyo, Japan), a fluorescent treponemal antibody absorption (FTA Abs) assay (Trepo-Spot IF, bioMerieux, Lyon, France), and a rapid plasma reagin (RPR) test (Becton Dickinson, Franklin Lakes, NJ). Sera were tested with the TPPA assay at 1:80 dilutions, and reactive sera were tested at dilutions of 1:160, 1:320, and 1:640. Sera were tested with the RPR test at 1:1 and 1:8 dilutions to screen for the prozone phenomenon. Reactive sera were tested with serial dilutions up to a titer of 1:512.
The source of the samples included multiple hospitals and clinics and represented a range of clinical services (adult medicine and surgery, women's hospital, pediatrics clinics, psychiatry clinics, prison health service, bone bank, tertiary eye clinics, HIV clinics, infectious diseases clinics, and sexual health clinics). Duplicate records were identified in the analysis by sorting data by medical record number, date of birth, and sex.
Serology results were interpreted as RPR-reactive confirmed syphilis (CIA reactive, RPR reactive), RPR-nonreactive confirmed syphilis (CIA reactive, RPR nonreactive, and TPPA and/or FTA Abs reactive), or "isolated" reactive CIA (CIA reactive, RPR nonreactive, TPPA nonreactive, and FTA Abs nonreactive). The level of chemiluminescence (defined by the S/CO ratio) in the CIA was compared by populations and correlated to the TPPA titer and log 2 RPR titer, using linear regression analysis. Categorical variables were compared using the χ 2 test, and continuous variables were compared using the Mann-Whitney U test. A P value of < .05 was considered statistically significant. All analyses were performed using GraphPad Prism, version 5 (GraphPad Software, La Jolla, CA). Finally, detailed clinical and serological assessment was undertaken for patients with isolated reactive CIA specimens from 2 clinical sites where repeat syphilis testing was routine clinical practice.
The study was approved by South Eastern Sydney Local Health District Human Research Ethics Committee.
RESULTS
Of the 28 261 serum specimens tested for T. pallidum infection, 1171 (4.1%) were reactive on CIA testing ( Table 1 ). The reference serum was a low-level control (mean S/CO = 2.1) and had a coefficient of variation of 8% over 100 replicate tests. On subsequent testing of the CIA-reactive specimens, 363 (31.1%) had RPR-reactive confirmed syphilis, and 675 (57.7%) had RPRnonreactive confirmed syphilis. A total of 133 CIA-reactive specimens (11.3%) were nonreactive on all further tests and were interpreted as isolated reactive CIA sera. When duplicated tests for the same patient were removed, there were 18 713 patients tested for syphilis. There were 869 patients (4.6%) with a reactive CIA specimen, of whom 82 (9.4%) had an isolated reactive CIA specimen. Discordant TPPA and FTA Abs results were observed in 7.9% of RPR-nonreactive confirmed syphilis samples. This was most common in patient groups with a high prevalence of confirmed syphilis. There were no differences observed between the distribution of discordant reactive TPPA or FTA Abs results (Table 1) .
When categorized by clinical site, the highest prevalence of reactive CIA specimens was in patients attending infectious diseases (24%), HIV (10.8%), tertiary eye (4.1%), pediatrics (3.9%), and sexual health (3.4%) clinics. The 4 isolated reactive CIA samples from the pediatric clinics involved 3 neonates who had mothers with reactive syphilis serology. The greatest number of isolated reactive CIA test specimens (117 of 133 [88%]) occurred in the populations with the highest prevalence of confirmed syphilis. However, the highest proportion was observed in the women's hospital group, where 42% of cases (8 of 19) with a reactive CIA specimen had an isolated reactive specimen. When the overall data were categorized by sex, male patients had a higher proportion of reactive CIA specimens (5.1% vs 2.0%; P < .0001) but a lower percentage of isolated reactive specimens as a proportion of reactive CIA specimens (8.2% vs 28.3%; P < .0001).
Significant differences were observed in the chemiluminescent S/CO ratio when reactive CIA specimens were classified according to the results of other serological tests. Isolated reactive CIA sera had a lower median S/CO ratio than sera with RPR-nonreactive confirmed syphilis and RPR-reactive confirmed syphilis (2.19 vs 11.57 vs 23.53; P < .0001). The CIA S/ CO ratio was similar between samples with isolated CIA reactivity and those with either a reactive TPPA or FTA Abs assay (median, 2.19 vs 2.32; P = .15). The median CIA S/CO ratio was significantly different between samples with either TPPA or FTA Abs reactivity and samples reactive on both assays (2.32 vs 12.37; P < .0001). When the distribution of the S/CO ratio was classified by high or low prevalence or sex, there were no significant differences observed. There was a possible trend that the isolated reactive CIA high-prevalence population had a lower median S/CO ratio than the low-prevalence population (2.06 vs 3.08; P = .05).
The relationships between CIA S/CO ratio and TPPA titer or RPR titer are shown in Figures 1 and 2 . The best correlation was observed between the CIA and TPPA assay (R 2 = 0.65).
Weak correlation was observed between the CIA and RPR test (R 2 = 0.36).
Detailed clinical and follow-up serological analysis was performed for 20 subjects with isolated reactive CIA sera (Table 2) . Of the 20 subjects, 16 were men who have sex with men, 4 were heterosexual, 3 were injection drug users, and 1 was pregnant. Fourteen of the cases were HIV coinfected. Overall, 11 (55%) had clinical or serological evidence of previous or subsequent syphilis. This included 7 patients with a documented history of syphilis and 7 patients with prior or subsequent serological evidence of syphilis. Therefore, 9 (45%) had no clinical or serological evidence of syphilis. On followup, 1 case seroreverted to CIA-nonreactive serology, 11 cases had persistently isolated CIA-reactive serology, 4 cases seroconverted to a reactive treponemal test (TPPA or FTA Abs) but remained RPR nonreactive, and no patients developed signs or symptoms of syphilis.
DISCUSSION
This is the first study to describe the performance of a CIA in a referral laboratory where all reactive specimens subsequently underwent testing with a nontreponemal test (the RPR test) and 2 treponemal assays (TPPA and FTA Abs assays). The rate of reactivity for the CIA was similar to previously published data, which are summarized in Table 3 [7] [8] [9] 19] . In the present study, 80.5% of isolated reactive CIA specimens (66 of 82) were from subjects from populations with the highest prevalence of syphilis. This suggests a higher rate of current or past T. pallidum infection (with partial treponemal antibody seroreversion) or BFP results for patients attending HIV, sexual health, infectious diseases, and ophthalmology clinics. The relatively high prevalence of reactive CIA sera in the pediatric group is likely due to testing bias toward children of (Table 3 ). Consistent with current CDC STD guidelines, the authors of both CDC laboratory reviews concluded that if sera are TPPA nonreactive, then syphilis is unlikely [8, 9] . As evidence for this recommendation, they cited a 3-fold lower rate of isolated reactive EIA or CIA specimens in the high-risk population, compared with the low-risk population [8] . Similarly, in the present study, the highest proportion of isolated reactive CIA specimens was observed in the women's hospital population, where 42% of women (8 of 19) with a reactive CIA specimen had an isolated reactive specimen. When the overall data were analyzed by sex, females had a higher percentage of isolated positive test results as a percentage of the reactive screening tests. Although these findings appear to agree with the CDC papers, we believe the interpretation that "syphilis is unlikely" may be subject to error. The absolute number of reactive specimens is small, and in our population an equally plausible explanation is that the women's hospital is a quaternary referral center for high-risk obstetric patients. Disadvantaged populations at increased risk of poor obstetric outcomes may be more likely to have prior or current T. pallidum infection. Most isolated reactive CIA specimens (117 of 133 [88%]) came from highprevalence populations in our study.
Other authors have attempted to assess the significance of cases with an isolated reactive EIA or CIA specimen through assessment of individual cases. Ooi et al [11] evaluated the significance of an isolated reactive EIA specimen in an Australian sexual health population. They found a greater proportion of cases occurred in a high-risk population and that patients with isolated reactive EIA sera usually reported high-risk behavior. The authors concluded that this was indicative of a true-positive syphilis result. Woznicova et al [10] [7] undertook a review of 255 CIA-reactive and RPR-nonreactive cases. Of cases that were negative on TPPA testing, 23% subsequently seroreverted to a CIA-nonreactive result, and the S/CO ratios were lower in the TPPA-nonreactive group, compared with the TPPA-reactive group. The authors concluded that these findings were suggestive of false-positive CIA results. Of concern, one patient in this group later became RPR reactive, suggesting possible early T. pallidum infection. We made similar observations of differences in CIA S/CO ratios between isolated reactive CIA specimens, RPR-nonreactive confirmed syphilis, and RPR-reactive confirmed syphilis. In contrast to conclusions by Park et al, we postulate that this distribution pattern may be caused by partial CIA seroreversion rather than by low-level S/CO ratio false-positive CIA results. It remains plausible that this population is at increased risk of BFP results, as well as true infection.
Once a patient has been treated for syphilis, guidelines and review articles suggest that treponemal antibodies are expected to remain detectable for life [20] . However, treponemal antibody seroreversion is documented in up to 24% of infectious syphilis cases diagnosed by means of traditional treponemal tests and is found more commonly in patients with HIV infection [21, 22] . Individual case review in the present study identified that 73% of subjects who had previous documented serological evidence of syphilis infection had evidence of seroreversion on traditional tests but had persistent seroreactivity on the syphilis CIA (Table 2 ). This is evidence that an isolated reactive CIA specimen may represent true but not necessarily "active" infection. In line with a seroreversion hypothesis, we identified 53 sera with discordant TPPA and FTA Abs results, suggesting that some subjects may have seroreverted on one traditional treponemal assay but not the other. Consistent with this hypothesis is the fact that the median CIA S/CO ratio for these subjects (2.32) was lower than that for subjects with sera that were reactive on both the TPPA and FTA Abs assays (12.37) and was similar to that for subjects with isolated CIA reactivity (2.19). The highest median S/CO ratio was observed in subjects with RPR-reactive syphilis. Previous studies may have misclassified subjects as isolated CIA reactive if only one other treponemal assay was performed. We also observed complete seroreversion (including seroreversion of the syphilis CIA) in 1 patient with a history of T. pallidum infection and treatment.
Other researchers have assessed this issue by adding treponemal line immunoassay (LIA) testing to the range of serological tests undertaken. Maple et al [23] studied 8 isolated EIA-reactive sera out of 226 specimens, (nonreactive on TPPA, FTA Abs, and venereal disease research laboratory [VDRL] testing) and found 3 (37.5%) to be reactive and 2 (25%) to have indeterminate reactivity on LIA testing. Similarly, Tsang et al [13] , who performed a battery of EIA, TPPA, FTA Abs, VDRL, RPR, and LIA analyses on 604 unselected sera, found that 3 of 15 samples (20%) that were reactive on EIA and nonreactive on TPPA, FTA Abs, VDRL, and RPR assays were reactive when assessed by LIA.
In the present study, a correlation was observed between the results in the treponemal CIA when compared with TPPA or RPR titers. However, in an individual sample, the CIA S/CO ratio does not reliably predict the RPR titer. Therefore, the S/CO ratio could not be used to monitor disease activity or classify clinical stage. For example, 14 sera with a TPPA titer > 1:320 had a low CIA S/CO ratio (1.1-5), and 144 RPR nonreactive sera had a high CIA S/CO ratio (>20).
Among the limitations of the present study, we could not calculate the sensitivity of the CIA because sera found to be nonreactive in the syphilis CIA were not assessed with other assays. At the population level, we have only categorized patients by clinical site, which precluded a careful clinical assessment of individual risk profiles. We were able, however, to review the clinic records of one-fourth of subjects with an isolated reactive CIA specimen. Another limitation of our data is that source categories may not be mutually exclusive. For example, antenatal clinics may have referred cases with reactive sera to the infectious diseases or sexual health clinics. We were able to reduce the likelihood of duplicates by sex, date of birth, and medical record number matching.
In conclusion, we suggest that an isolated treponemal CIA may represent true evidence of T. pallidum infection, at least in some cases. The result should not be ignored because there may be consequences for missing other sexually transmitted infections and notifying sexual contacts. We have demonstrated seroreversion for 3 treponemal tests (CIA, TPPA, and FTA Abs), as well as seroconversion from isolated CIA reactive to RPR-negative confirmed T. pallidum infection. We have also demonstrated that the level of chemiluminescence in the CIA is similar between subjects with isolated CIA reactivity and those with reactivity on either TPPA or FTA Abs testing but not both, consistent with the hypothesis of incomplete seroreversion as an explanation for the phenomenon of "isolated" CIA reactivity. The majority of patients with reactive CIA specimens had a history or serological evidence of syphilis on detailed review and follow-up. Therefore, we caution against the interpretation of CIA-reactive, RPR-nonreactive, TPPA-nonreactive, FTA Abs-nonreactive sera as false-positive reactions.
